Population-nosological research biobank of the National Medical Research Center for Therapy and Preventive Medicine: analysis of biosamples, principles of collecting and storing information

Aim. To analyze the structure of clinical data, as well as the principles of collecting and storing related data of the biobank of the National Medical Research Center for Therapy and Preventive Medicine (hereinafter Biobank).

Material and methods. The analysis was carried out using the documentation available in the Biobank, as well as the databases used in its work. The paper presents clinical data on biosamples available in the Biobank as of August 18, 2021.

Results. At the time of analysis, the Biobank had 373547 samples collected from 54192 patients within 37 research projects. The article presents the analysis of data representation and quantitative assessment of the presence/absence of common diagnoses in clinical projects. Approaches to documenting clinical information associated with biological samples stored in the Biobank were assessed. The methods and tools used for standardization and automation of processes used in the Biobank were substantiated.

Conclusion. The Biobank of the National Medical Research Center for Therapy and Preventive Medicine is the largest research biobank in Russia, which meets all modern international requirements and is one of the key structures that improve the research quality and intensify their conduct both within the one center and in cooperation with other biobanks and scientific institutions. The collection and systematic storage of clinical abstracts of biological samples is an integral and most important part of the Biobank’s work.

1. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med. 1996;74(6):297-312. doi:10.1007/BF00207507.

2. Hewitt R, Watson P. Defining biobank. Biopreserv Biobank. 2013;11(5):309-15. doi:10.1089/bio.2013.0042.

3. NHMRC. National Health and Medical Research Council “Biobanks information paper”. Canberra. 2010. https://www.nhmrc.gov.au/sites/default/files/documents/attachments/ Biobanks-information-paper-2010.pdf (28 October 2021).

4. Creation and Governance of Human Genetic Research Databases. Paris: OECD, 2006. 159 p. doi:10.1787/9789264028531-en.

5. Mikhailova AA, Nasykhova YA, Muravyov AI, et al. Towards the creation of a unified glossary of Russian biobanks. Cardiovascular Therapy and Prevention. 2020;19(6):2710. (In Russ.) doi:10.15829/1728-8800-2020-2710.

6. ISO-ISO 20387:2018-Biotechnology — Biobanking — General requirements for biobanking. https://www.iso.org/standard/67888.html. (28 October 2021).

7. Borisova AL, Pokrovskaya MS, Meshkov AN, et al. ISO 20387 biobanking standard. Analysis of requirements and experience of implementation. Clin Lab Diagnostics. 2020;65(9):587-92. (In Russ.) 0.18821/0869-2084-2020-65-9-587-592.

8. Pokrovskaya MS, Sivakova OV, Efimova IA, et al. Biobanking as a necessary tool for research in the field of personalized medicine in the scientific medical center. Pers Med. 2019;16(6):501­9. doi:10.2217/pme­2019­0049.

9. Moore HM, Kelly A, Jewell SD, et al. Biospecimen Reporting for Improved Study Quality. Biopreserv Biobank. 2011;9(1):57­70. doi:10.1089/bio.2010.0036.

10. Müller H, Dagher G, Loibner M, et al. Biobanks for life sciences and personalized medicine: importance of standardization, biosafety, biosecurity, and data management. Curr Opin Biotechnol. 2020;65:45­51. doi:10.1016/j.copbio.2019.12.004.

11. Annaratone L, Palma GD, Bonizzi G, et al. Basic principles of biobanking: from biological samples to precision medicine for patients. Virchows Arch. 2021;479(2):233. doi:10.1007/s00428­021­03151­0.

12. Doludin YV, Borisova AL, Pokrovskaya MS, et al. Current best practices and biobanking recommendations. Clin Lab Diagnostics. 2019;64(12):769­76. (In Russ.) doi:6710.18821/0869­2084­2019­64­12­769­776.

13. Biobanks for Europe — Publications Office of the EU. Brussels: European Commission; 2012. 72 p. https://op.europa.eu/en/publication­detail/­/publication/629eae10­53fc­4a52­adc2­210d4fcad8f2. ISBN 978­92­79­22858­2. doi:10.2777/68942 (28 October 2021).

14. Harati MD, Williams RR, Movassaghi M, et al. An introduction to starting a biobank. Methods Mol Biol. 2019;1897:7-16. doi:10.1007/978-1-4939-8935-5_2.

15. Campbell LD, Astrin JJ, DeSouza Y, et al. The 2018 Revision of the ISBER Best Practices: Summary of Changes and the Editorial Team’s Development Process. Biopreserv Biobank. 2018;16(1):3-6. doi:10.1089/bio.2018.0001.

16. Boytsov SA, Drapkina OM, Shlyakhto EV, et al. Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. Ten years later. Cardiovascular Therapy and Prevention. 2021;20(5):3007 (In Russ.) doi:10.15829/1728-8800-2021-3007

17. 17 Pokrovskaya MS, Borisova AL, Metelskaya VA, et al. Role of biobanking in managing large-scale epidemiological studies. Cardiovascular Therapy and Prevention. 2021;20(5):2958. (In Russ.) doi: 10.15829/1728-8800-2021-2958.

18. Sivakova OV, Pokrovskaya MS, Efimova IA, et al. Quality control of serum and plasma samples for scientific research. The Russian Journal of Prtventive Medicine. 2019;22(5):91-7 (In Russ.) doi:10.17116/profmed20192205191.

19. Sivakova OV, Pokrovskaya MS, Metelskaya VA, et al. International rules for description of biospecimens are an important factor in improving the quality of researches. The Russian Journal of Preventive Meditsine. 2019;22(6):95. (In Russ.) doi: 10.17116/profmed20192206295.

20. Begley CG, Ellis LM. Raise standards for preclinical cancer research. Nature. 2012;483(7391):531-3. doi:10.1038/483531a.

21. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov. 2011; 10(9):712-2. doi:10.1038/nrd3439-c1.

22. Manders P, Peters TMA, Siezen AE, et al. A Stepwise Procedure to Define a Data Collection Framework for a Clinical Biobank. Biopreserv Biobank. 2018;16(2):138-47 doi:10.1089/bio.2017.0084.

23. EGISZ (In Russ.) ЕГИСЗ. https://egisz.rosminzdrav.ru/. (28 October 2021).

24. Paskal W, Paskal AM, D^bski T, et al. Aspects of Modern Biobank Activity — Comprehensive Review. 2018;24(4):771-85. doi:10.1007/s12253-018-0418-4.

25. Hutchinson E. Towards individualized cancer therapy: Challenges and prospects. Mol Oncol. 2014;8(1): 1-8. doi:10.1016/j.molonc.201312.008.

26. Ramensky VE, Ershova AI, Zaicenoka M, et al. Targeted Sequencing of 242 Clinically Important Genes in the Russian Population From the Ivanovo Region. Front Genet. 2021;12:709419. doi:10.3389/fgene.2021.709419.

27. Meshkov A, Ershova A, Kiseleva A, et al. The LDLR, APOB, and PCSK9 variants of index patients with familial hypercholesterolemia in Russia. Genes (Basel). 2021; 12(1):1-17 doi:10.3390/genes12010066.

28. Kiseleva A, Klimushina M, Sotnikova E, et al. Cystic Fibrosis Polymorphic Variants in a Russian Population. Pharmgenomics. Pers Med. 2020;13:679-86. doi:10.2147/PGPM.S278806.

29. Kiseleva AV, Klimushina MV, Sotnikova EA, et al. A Data-Driven Approach to Carrier Screening for Common Recessive Diseases. J Pers Med. 2020;10(3):140. doi:10.3390/jpm10030140.

30. Gumanova NG, Gavrilova NE, Chernushevich OI, et al. Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis. Biomarkers. 2017;22(3-4):239-45. doi: 10.1080/1354750X.2016.1201539.

31. Metelskaya VA, Gavrilova NE, Gumanova NG, et al. Combination of visual and metabolic markers in assessment of probability of presence and severity of atherosclerosis of coronary arteries. Kardiologiia. 2016;56(7):47-53. (In Russ.) doi: 10.18565/cardio.2016.7.47-53.

32. Smetnev S, Klimushina M, Kutsenko V, et al. Associations of SNPs of the ADIPOQ gene with serum adiponectin levels, unstable angina, and coronary artery disease. Biomolecules. 2019;9(10):537 doi:10.3390/biom9100537

33. Barbitoff YA, Serebryakova EA, Nasykhova YA, et al. Identification of Novel Candidate Markers of Type 2 Diabetes and Obesity in Russia by Exome Sequencing with a Limited Sample Size. Genes (Basel). 2018;9(8):415. doi:10.3390/genes9080415.

34. Drapkina OM. Russian National Association of Biobanks and Biobanking Specialists — a tool for integrating Russian biobanks and increasing the efficiency of biomedical research Drapkina O. M. Cardiovascular Therapy and Prevention. 2020;19(6):2757 (In Russ.) doi:10.15829/1728-8800-2020-2757.

35. About the association — NASBIO. (In Russ.) Об ассоциации — НАСБИО. http://nasbio.ru/about_us/ob-assocziaczii.html. (28 October 2021).